Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease
N. Jafari, A. Chen, M. Kolla, I. R. Pompa, Y. Qiu, R. Yu, P. Llevenes, C. S. Ennis, J. Mori, K. Mahdaviani, M. Halpin, G. A. Gignac, C. M. Heaphy, S. Monti, G. V. Denis
This study identifies plasma exosomal miRNAs associated with T2D that induce EMT and immune checkpoint expression in prostate cancer cells.
bioRxiv · Feb 1, 2022Cancer Biology